Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06914674
PHASE2
Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas
Sponsor: Fudan University
View on ClinicalTrials.gov
Summary
Tamoxifen for Solid Pseudopapillary Tumor of the Pancreas
Key Details
Gender
All
Age Range
14 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2025-03-20
Completion Date
2028-02-28
Last Updated
2025-04-06
Healthy Volunteers
No
Conditions
Interventions
DRUG
Tamoxifen 20 mg
Tamoxifen: 10 mg orally twice daily. Combination therapy: Chemotherapy, radiotherapy, surgery, or other treatments per NCCN guidelines and patient condition.
Locations (1)
Shanghai Cancer Center
Shanghai, China